MedTrace Logo

Bilberry-containing Capsules for Dry Eye Mitigation

NCT05737108 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-02-18

No results posted yet for this study

Summary

This study investigates whether the oral intake of a bilberry capsule product may relieve dry eye symptoms. Participants will be aged between 20 - 65 years of age, with confirmed diagnosis of dry eye status. The participants will be assessed for several parameters and asked to take 4 bilberry capsules per day for 30 days. The parameters will include ocular surface health, tear volume, tear quality, intraocular pressure, and tear compositions. After the 30 days are completed, the participants will be assessed again for the same parameters.

Conditions

  • Dry Eye

Interventions

DIETARY_SUPPLEMENT

Bilberry capsule product

A specific bilberry capsule product, containing bilberry dried extracts at 23.2 mg and bilberry powder at 3.2 mg will be given to participants for oral intake for 30 days. 30 days of Bilberry capsule product or placebo with crossover to the other.

DIETARY_SUPPLEMENT

Placebo(starch)

30 days of placebo or Bilberry capsule product with crossover to the other.

Sponsors & Collaborators

  • Glory Kingdom Corporation

    collaborator UNKNOWN

  • Chung Shan Medical University

    lead OTHER

Principal Investigators

  • David Pei-Cheng Lin, PhD · Chung Shan Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-24
Primary Completion
2023-07-31
Completion
2023-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05737108 on ClinicalTrials.gov